Danish Medicines Agency considers reporting Europharma DK again
Already once this year, the Danish Medicines Agency reported the parallel importer Europharma DK to the police. Now, the agency considers reporting the company again after a new suspension of Europharma’s authorization for secondary repackaging and release of medicinal products.
BY MIKKEL AABENHUS HEMMINGSEN
Once again, the Esbjerg-based parallel importer Europharma DK has been ordered to stop its manufacturing and distribution of drugs to the Danish market.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
